Long term survival of vinorelbine (N) and trastuzumab (H) as first line therapy for HER2-positive metastatic breast cancer patients (HER2+MBC) (pts)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.587 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 587-587 ◽

Author(s):

A. Chan ◽

L. Petruzelka ◽

M. Untch ◽

M. Martin ◽

M. Gil Gil ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Term Survival ◽

First Line Therapy ◽

Download Full-text

Long-term survival in patients with HER2-positive metastatic breast cancer treated with trastuzumab as first-line therapy: Seven-year follow-up of the French Observational Hermine Study.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.617 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 617-617

Author(s):

E. Antoine ◽

F. Dalenc ◽

C. Hebert ◽

P. Rivera ◽

G. Romieu ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Her2 Positive ◽

Term Survival ◽

First Line Therapy ◽

Download Full-text

Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from 2013 to 2016

10.1016/s0960-9776(19)30245-0 ◽

2019 ◽

Vol 44 ◽

pp. S64

Author(s):

K. Suleman ◽

A. Mushtaq ◽

E. Haque ◽

A. Badran ◽

D. Ajarim ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Retrospective Review ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Her2 Positive ◽

First Line Therapy ◽

Download Full-text

Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients

Expert Review of Anticancer Therapy ◽

10.1586/era.12.107 ◽

2012 ◽

Vol 12 (11) ◽

pp. 1391-1405 ◽

Author(s):

Lucia Del Mastro ◽

Matteo Lambertini ◽

Claudia Bighin ◽

Alessia Levaggi ◽

Alessia D’Alonzo ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Her2 Positive ◽

First Line Therapy ◽

Download Full-text

Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial

British Journal of Cancer ◽

10.1038/sj.bjc.6603351 ◽

2006 ◽

Vol 95 (7) ◽

pp. 788-793 ◽

Author(s):

A Chan ◽

◽

M Martin ◽

M Untch ◽

M G Gil ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line Therapy ◽

Line Therapy ◽

Download Full-text

Final results from PERUSE, a global study of pertuzumab (P), trastuzumab (H) and investigator’s chosen taxane as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer (LR/mBC)

10.1055/s-0041-1730221 ◽

2021 ◽

Author(s):

A Schneeweiss ◽

D Miles ◽

E Ciruelos ◽

F Puglisi ◽

T Peretz-Yablonski ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Her2 Positive ◽

First Line Therapy ◽

Line Therapy ◽

Global Study ◽

Locally Recurrent

Download Full-text

Abstract P6-17-14: Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: A multicenter, collaborative, open-label, phase II clinical trial for the SBCCSG-36 investigators

10.1158/1538-7445.sabcs18-p6-17-14 ◽

2019 ◽

Author(s):

K Inoue ◽

J Ninomiya ◽

K Okubo ◽

T Nakakuma ◽

H Yamada ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Her2 Positive ◽

First Line Therapy ◽

Line Therapy ◽

Open Label Phase

Download Full-text

Long-term outcome of HER2 positive metastatic breast cancer patients treated with first-line trastuzumab

10.1016/j.breast.2015.09.008 ◽

2015 ◽

Vol 24 (6) ◽

pp. 751-757 ◽

Author(s):

B. Yeo ◽

K. Kotsori ◽

K. Mohammed ◽

G. Walsh ◽

I.E. Smith

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Term Outcome ◽

Long Term Outcome

Download Full-text

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients

European Journal of Cancer ◽

10.1016/j.ejca.2018.03.013 ◽

2018 ◽

Vol 95 ◽

pp. 93-101 ◽

Author(s):

E. Jacquet ◽

A. Lardy-Cléaud ◽

B. Pistilli ◽

S. Franck ◽

P. Cottu ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Hormone Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line Therapy ◽

Hormone Receptor Positive ◽

Download Full-text

Trastuzumab combined with doublet or single-agent chemotherapy as first-line therapy for HER2-positive metastatic breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-017-4592-y ◽

2017 ◽

Vol 168 (2) ◽

pp. 337-348 ◽

Author(s):

Y. F. Yu ◽

Y. Wang ◽

T. P. Fu ◽

K. Chen ◽

J. Q. Liu ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Single Agent ◽

Metastatic Breast ◽

Her2 Positive ◽

First Line Therapy ◽

Line Therapy ◽

Single Agent Chemotherapy

Download Full-text

Evaluation of vinorelbine (N) and trastuzumab (H) as first-line therapy for patients (pts) with HER2- positive metastatic breast cancer (HER2+ MBC): Impact on clinical response and cardiac function

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.636 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 636-636

Author(s):

V. Guillem Porta ◽

M. Martin ◽

M. Gil Gil ◽

P. Kellokumpu-Lehtinen ◽

F. Majois ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cardiac Function ◽

Clinical Response ◽

Metastatic Breast ◽

Her2 Positive ◽

First Line Therapy ◽

Download Full-text